Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient
申请人:Habashita Hiromu
公开号:US20060019977A1
公开(公告)日:2006-01-26
Spiroheterocyclic ring derivatives of the formula (I)
(wherein R
1
is H, alkyl, alkenyl, etc.; R
2
is keto, thioketo, alkyl, etc.; R
3
is alkyl, alkenyl, etc.; AB ring is fused bi-cyclic ring or spiro ring), quaternary ammonium salts thereof, N-oxides thereof, non-toxic salts thereof, or pharmaceutical compositions comprising them, as an active ingredient. The compounds of the formula (I) regulate the effect of chemokine/chemokine receptor, they are used for prevention and treatment of various inflammatory diseases, allergic diseases, immunosuppression, cancer metastasis and acquired immune deficiency syndrome etc.
式 (I) 的螺杂环衍生物
(其中 R
1
是 H、烷基、烯基等;R
2
是酮、硫酮、烷基等;R
3
是烷基、烯基等;AB 环是融合双环或螺环)、其季铵盐、其 N-氧化物、其无毒盐或包含它们的药物组合物作为活性成分。式(I)化合物具有调节趋化因子/趋化因子受体的作用,可用于预防和治疗各种炎症性疾病、过敏性疾病、免疫抑制、癌症转移和获得性免疫缺陷综合征等。